Skip to main content
. 2016 Dec 21;2016(12):CD004371. doi: 10.1002/14651858.CD004371.pub4

Kardas 2013.

Study characteristics
Methods Parallel randomised controlled clinical trial
Randomisation ratio: 1:1
Equivalence design: (2‐sided confidence interval)
Open‐label
Participants N recruited = 198
N randomised = 198 (89 control, 107 intervention)
N reported = 196
Mean age 59.6 ± 9.1 years, 75.5% women
INCLUSION CRITERIA
Outpatients with untreated hyperlipidaemia (total cholesterol ≥ 250 mg/dL) aged 40 ‐ 80 years (59.6 ± 9.1 years) were enrolled
EXCLUSION CRITERIA
Mental illness, dependence on other people’s care, and/or medication taking, being at risk of not completing the study due to alcoholism, psychoactive substance abuse, homelessness etc., porphyria, unstable angina, NYHA class III or IV heart failure, acute infections, liver disease (cirrhosis), or significantly elevated transaminases (level ≥ 3 times above the normal values), allergy to simvastatin, or any other known contraindications to its use, pregnancy, and lactation.
COUNTRY/SETTING: primary care centers in Poland
STUDY PERIOD: Not reported
Interventions CONTROL GROUP
All patients who were enrolled in the study were prescribed simvastatin at the initial dose of 20 mg to be taken once daily in the evening
INTERVENTION GROUP
Intervention group received counselling every 8 weeks and were instructed to adopt routine evening activity as a reminder
Outcomes PRIMARY OUTCOME: adherence expressed as Medication Possession Ratio, calculated as the proportion of the number of days during which the participant was in possession of simvastatin, over the total number of days of the follow‐up period.
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection bias)
All outcomes Unclear risk Unblinded open‐label study
Incomplete outcome data (attrition bias)
All outcomes Low risk 2 participants lost to attrition
Selective reporting (reporting bias) Low risk All outcomes reported